Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in April
Tenpoint Therapeutics, Ltd. (“Tenpoint”), a global, clinical-stage biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announced that the Company will participate in two upcoming investor conferences in April.
